PERSPECTA

News from every angle

Back to headlines

Biotech Fund Sells Nuvalent Shares After 29% Stock Surge

A biotech fund has divested $84 million worth of Nuvalent shares, despite the stock experiencing a 29% increase.

23 Feb, 15:21 — 23 Feb, 15:21
PostShare

Sources

Showing 1 of 1 sources